Related Experiment Video
Updated: May 16, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Characterization of pyruvate dehydrogenase subunit B and enolase as plasminogen-binding proteins in Mycoplasma
Cindy Thomas1, Enno Jacobs1, Roger Dumke1
1Dresden University of Technology, Medical Faculty Carl Gustav Carus, Institute of Medical Microbiology and Hygiene, Fetscherstrasse 74, D-01307 Dresden, Germany.
Abstract:
The obligate pathogenic mycoplasma species Mycoplasma pneumoniae uses a limited but effective repertoire of virulence factors to infect and colonize the human respiratory tract. Besides the development of a unique adhesion complex and the expression of tissue-damaging factors, surface-located glycolytic enzymes and their capacity to bind to components of the human extracellular matrix (ECM) support pathogen-host interactions. Here, we demonstrated that the glycolytic enzymes enolase (Mpn606) and pyruvate dehydrogenase subunit B (Mpn392; PDHB) of M. pneumoniae show concentration-dependent binding to human plasminogen. Monospecific polyclonal antisera against both recombinant proteins reduced the binding to plasminogen significantly. The surface location of PDHB but not of enolase was demonstrated using Triton X fractionation of M. pneumoniae total protein content, membrane fractionation, colony blotting, mild proteolysis of mycoplasma cells, and immunofluorescence tests. To characterize the binding site of plasminogen in surface-displaced PDHB, the mycoplasmal protein was separated into four recombinant proteins followed by investigation of the binding behaviour of peptides that overlap the protein part interacting with plasminogen. Spot analysis resulted in a novel region of 12 amino acids (FPAMFQIFTHAA, position 91 to 102 of PDHB), which is responsible exclusively for binding of human plasminogen and also interacts in a dose-dependent manner with this host protein. The data indicate that the plasminogen-binding enzymes enolase and especially the surface-associated PDHB may contribute to the pathogenesis of M. pneumoniae infections.
Insights
Mycoplasma pneumoniae utilizes surface-associated pyruvate dehydrogenase subunit B (PDHB) to bind human plasminogen, a key interaction potentially contributing to respiratory tract infections. This binding is mediated by a specific 12-amino acid region on PDHB.
Area of Science:
- Microbiology
- Molecular Biology
- Pathogen-Host Interactions
Background:
- Mycoplasma pneumoniae is an obligate pathogen causing respiratory infections.
- Surface-located glycolytic enzymes facilitate pathogen-host interactions by binding extracellular matrix components.
- Understanding these interactions is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate the binding of M. pneumoniae glycolytic enzymes, enolase and pyruvate dehydrogenase subunit B (PDHB), to human plasminogen.
- To determine the surface localization of these enzymes and characterize the specific binding site for plasminogen on PDHB.
Main Methods:
- Recombinant protein expression and purification.
- Enzyme-plasminogen binding assays using polyclonal antisera.
- Cell fractionation, colony blotting, mild proteolysis, and immunofluorescence for surface localization.
- Peptide mapping to identify the plasminogen-binding site on PDHB.
Main Results:
- Both enolase and PDHB of M. pneumoniae bind human plasminogen in a concentration-dependent manner.
- PDHB was confirmed to be surface-associated, while enolase's surface localization was not definitively shown.
- A novel 12-amino acid region (FPAMFQIFTHAA) on PDHB was identified as the exclusive binding site for human plasminogen.
Conclusions:
- Surface-associated PDHB and enolase from M. pneumoniae bind human plasminogen.
- The identified 12-amino acid region on PDHB is critical for plasminogen binding.
- These interactions may play a significant role in the pathogenesis of M. pneumoniae infections.
More Related Videos
Related Concept Videos
Atypical Pneumonia
Bacterial Phylum Tenericutes
Bacterial Meningitis II: Pathophysiology
Enzyme Inhibition
Pneumonia II: Pathophysiology

